What We’re Reading: Medicare Lawsuit Dismissed; COVID Isolation Guidelines; Millions Have Long COVID

Lawsuit Dismissed Against Drug Price Negotiation Program

On Monday, a federal judge in Austin, Texas, dismissed a lawsuit filed by Pharmaceutical Research and Manufacturers of America (PhRMA) challenging Medicare's new drug price negotiation program, according to Reuters. The program aims to save billions annually by allowing Medicare to negotiate drug prices with manufacturers. Despite the setback for PhRMA, other lawsuits by major drugmakers are ongoing, indicating further legal battles as the cases may reach federal appeals courts and potentially the US Supreme Court.

CDC Plans to Loosen COVID Isolation Guidelines

The CDC is set to release updated guidance that will relax COVID-19 isolation recommendations, allowing Americans who test positive to return to work and school sooner, according to The Washington Post. The move, driven by changes in the COVID-19 landscape and immunity levels, aligns with protocols for avoiding transmission of the flu and respiratory syncytial virus. Under the new approach, individuals can end isolation if they have been fever free for at least 24 hours without medication and their symptoms are mild and improving.

Studies Shed Light on Long COVID in Children and Pregnant Individuals

Recent studies provide insights into the occurrence and effects of long COVID among children and pregnant individuals, according to CNN. One study found that around 10% of pregnant people experience persistent symptoms such as fatigue and dizziness after contracting COVID-19. Another study suggests that up to 6 million children may develop long COVID, with symptoms that include respiratory problems and an increased risk of autoimmune conditions such as type 1 diabetes.